IMMUNITYBIO, INC. Operating Leases, Future Minimum Payments, Due in Four Years
IMMUNITYBIO, INC. (IBRX) had Operating Leases, Future Minimum Payments, Due in Four Years of $3.54 million as of 2019-03-31, per its 10-Q filed 2019-05-08.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears · last filed 2019-05-08
- 2019-03-31: Operating Leases, Future Minimum Payments, Due in Four Years $3.54M.
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $3.54M.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $3.44M.
- 2016-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $4.06M.
| Period end | Operating Leases, Future Minimum Payments, Due in Four Years |
|---|---|
| 2019-03-31 | $3.54M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $3.54M 10-K · filed 2019-03-13 |
| 2017-12-31 | $3.44M 10-K · filed 2018-03-12 |
| 2016-12-31 | $4.06M 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |